Clinical Trial Update: Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy and safety of Thealoz for moderate dry eye syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Thealoz

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Moderate Dry Eye Syndrome | Phase 4 | Status: COMPLETED